案例报告:黑质纹状体多巴胺通路破坏所致霍姆斯震颤对多巴胺替代治疗有效
本文报告一例渐进性左侧霍姆斯震颤(HT)患者,伴帕金森综合征、感觉减退、右侧动眼神经麻痹、认知功能障碍及嗜睡,影像学显示右侧丘脑和中脑胶质瘤,多巴胺转运体成像显示右侧尾状核和壳核多巴胺能去神经支配,程度重于帕金森病预期,多巴胺能药物治疗后震颤及相关症状显著改善。
要点
- 霍姆斯震颤可因中脑大脑脚病变中断黑质纹状体通路所致。
- 纹状体多巴胺转运体成像可用于评估突触前多巴胺功能障碍。
- 多巴胺能药物治疗可能改善霍姆斯震颤及相关症状。
核心结论
- 中脑大脑脚病变导致的霍姆斯震颤可能因黑质纹状体通路中断而发生。
- 纹状体多巴胺功能成像可能有助于评估突触前多巴胺功能障碍并指导治疗。
研究设计与样本
- 本文为个案报道,报告一例渐进性左侧霍姆斯震颤患者的临床资料。
主要发现
- 患者为其他方面健康的男性,表现为渐进性左侧霍姆斯震颤,伴帕金森综合征、感觉减退、右侧动眼神经麻痹、认知功能障碍及嗜睡。
- 影像学检查显示右侧丘脑和中脑胶质瘤。
- 多巴胺转运体成像显示右侧尾状核和壳核显著多巴胺能去神经支配,其纹状体多巴胺转运体缺陷程度重于帕金森病患者的预期。
- 多巴胺能药物试验导致震颤及相关症状显著改善。
临床怎么用
- 作者认为,纹状体多巴胺功能成像可能有助于评估突触前多巴胺功能障碍并指导治疗。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Holmes tremor (HT), also known as midbrain, rubral, or cerebellar pathway outflow tremor, occurs because of disturbances of the cerebellothalamic pathway. This tremor is usually related to lesions in the midbrain peduncular region involving the superior cerebellar peduncle, the red nucleus, and possibly the nigrostriatal circuitry. Common etiologies resulting in HT include tumor, ischemia, and demyelination. We report a case of progressive left-sided HT in an otherwise healthy man with additional symptoms of parkinsonism, hypoesthesia, right oculomotor nerve palsy, cognitive dysfunction, and hypersomnolence. Imaging investigations revealed a right-sided thalamic and midbrain glioma. Dopamine transport imaging demonstrated significant dopaminergic denervation in the right caudate and putamen. The degree of striatal dopamine transporter deficiency was more severe than expected in a patient with Parkinson disease. A trial of dopaminergic agent resulted in significant improvement of the tremor and associated symptoms. Interruption of the nigrostriatal pathway can occur in cases of HT because of midbrain peduncular lesion. The striatal dopaminergic function imaging may have a role in assessing presynaptic dopamine dysfunction and guiding treatment.
引用
- Yen K, Yaworski A, Bussiere M, et al. Pearls & Oy-sters: A Case Report of Holmes Tremor Due to Nigrostriatal Dopamine Disruption That Responded to Dopamine Replacement Therapy. Neurology. 2022. PMID: 35803716. doi:10.1212/WNL.0000000000201000
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。